Is Climb Bio, Inc. profitable?

Climb Bio, Inc. is not currently profitable: it reported a net loss of $52.8M over the trailing twelve months.

What is Climb Bio, Inc.'s earnings per share?

Climb Bio, Inc.'s diluted EPS over the trailing twelve months is $-0.77.

Where does Climb Bio, Inc.'s income statement data come from?

Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Climb Bio, Inc. CLYM Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$9.37M-45.9%	$13.74M+131%	$9.07M+45.4%	$6.58M+529%	$17.33M+1,488%
General and administrative	$5.84M+2.6%	$5.56M+12.2%	$5.82M+6.0%	$4.1M+11.9%	$5.69M+197%
Total operating expenses	$15.21M-33.9%	$19.3M+76.8%	$14.89M+26.9%	$10.68M-81.1%	$23.02M+666%
Operating income	-$15.21M+33.9%	-$19.3M-76.8%	-$14.89M-26.9%	-$10.68M+81.1%	-$23.02M-666%
Interest income	$1.51M-33.8%	$1.83M-27.6%	$2.04M-26.9%	$2.17M+46.3%	$2.29M+70.5%
Other income (expense), net	$1.49M-33.4%	$1.78M-28.7%	$2M-29.4%	$2.01M+35.6%	$2.24M+71.0%
Net income	-$13.72M+34.0%	-$17.52M-108%	-$12.89M-44.9%	-$8.67M+84.2%	-$20.78M-1,125%
Diluted earnings per share	-$0.20+35.5%	-$0.25—	-$0.19-46.2%	-$0.13+92.8%	-$0.31-417%
Basic earnings per share	-$0.20+35.5%	-$0.25—	-$0.19-46.2%	-$0.13+92.8%	-$0.31-417%
Weighted-average shares, diluted	68.2M+1.1%	67.8M+40.8%	68M+1.5%	67.6M+123%	67.5M+144%
Weighted-average shares, basic	68.2M+1.1%	67.8M+40.8%	68M+1.5%	67.6M+123%	67.5M+144%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$14M+31.8%	-$17.55M-104%	-$12.74M-46.5%	-$8.63M+84.3%	-$20.52M-1,111%
EBIT	-$15.21M+33.9%	-$19.3M-76.8%	-$14.89M-26.9%	-$10.68M+81.1%	-$23.02M-666%
EBITDA	-$15.17M+34.1%	-$19.27M-76.6%	-$14.86M-26.7%	-$10.64M—	-$23.02M—
EBITDA	-$15.17M+34.1%	-$19.27M-76.6%	-$14.86M-26.7%	-$10.64M—	-$23.02M—
EBIT	-$15.21M+33.9%	-$19.3M-76.8%	-$14.89M-26.9%	-$10.68M+81.1%	-$23.02M-666%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Climb Bio, Inc. profitable?: Climb Bio, Inc. is not currently profitable: it reported a net loss of $52.8M over the trailing twelve months.
What is Climb Bio, Inc.'s earnings per share?: Climb Bio, Inc.'s diluted EPS over the trailing twelve months is $-0.77.
Where does Climb Bio, Inc.'s income statement data come from?: Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.